Table 3.
Therapy and outcome from cats of groups no. 1–6 (recovery rate and time).
| Group | Therapy | Recovered | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Number | Infusion Ringer-Lactated | Food I. | Food II. | Complete recovery | died | Recovery Time (Days) | ||||
| of Cases | Penicillin | total | rec. | total | rec. | min | max | |||
| 1 | 19 | iv for 2 d | 17 | 15 | 2 | 2 | 17 | 0 | 5 | 10 |
| 2 | 23 | sc for 2-3 d | 21 | 20 | 2 | 2 | 22 | 0 | 7 | 15 |
| 3 | 11 | iv for 2-3 d | 11 | 7 | 0 | 0 | 7 | 0 | 7 | 16 |
| 4 | 5 | iv for 5–7 d | 5 | 3 | 0 | 0 | 3 | 0 | 14 | 28 |
| 5 | 5 | — | 5 | 0 | 0 | 0 | 0 | 5 | — | — |
| 6 | 3 | iv for 2-3 d | 3 | 3 | 0 | 0 | 3 | 0 | 10 | 15 |
| Total | 66 | — | 62 | 48 | 4 | 4 | 52 | 5 | 5 | 28 |
rec.: recovered; min: minimum; max: maximum: sc: subcutaneously; iv: intravenously; Food I and Food II: two different brands of commercial cat food contaminated with salinomycin; Group 1: LMN paraparesis; Group 2: LMN paraplegia; Group 3: LMN tetraparesis; Group 4: LMN tetraplegia; Group 5: LMN tetraplegia, cranial nerve deficits, and dyspnoea; Group 6: vestibular syndrome and autonomic signs.